Press Releases

High Pressure Contrast Media Injectors Market is Anticipated to Grow US$ 462.8 Mn By 2030

The worldwide High Pressure Contrast Media Injectors market measurement is anticipated to achieve USD 462.8 million by 2030 and is anticipated to increase at a CAGR of 20.1% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38478

Growth Factors

 The market is primarily driven by the factors such as the increasing number of target diseases, such as cardiovascular diseases, neurovascular, and cancer also the rising demand for minimally invasive surgical procedures is a major factor expected to boost the market during the forecast period.

Technological advances have contributed to the expansion of the market. For instance, several advancements in contrast media injector technology have been made to reduce contrast media waste and automate data collection about the dose a patient receives. Automated injector systems, for example, precisely gather the amount of contrast media used, and companies have begun to offer personalized doses for patients based on data from EMR or PACS. Syringeless injectors are one such advancement in lowering contrast media waste.

Report Highlights

The consumable segment dominated the market and accounted for the largest revenue share of 71.3% in 2020. The segment is expected to witness a CAGR of 11.7% during the forecast period. The rapid growth of this segment can be attributed to the factors such as high usage of disposable devices owing to the high safety, as well as features like user-friendliness, high efficiency, and less contrast media wastage. The consumable segment is further segmented into syringes, tubings, and others.

The single head segment dominated the market and accounted for the largest revenue share of 54.6% in 2020. As angiography, CT, and MRI are the most common applications. Furthermore, demand in emerging economies such as China, India, and Brazil is expected to be fueled by the low cost of these devices as compared to other systems. This segment is also anticipated to prosper from the emergence of various new products.

The interventional cardiology segment dominated the market for high pressure contrast media injectors and accounted for the largest revenue share of 35.5% in 2020. The segment is expected to witness a CAGR of 21.8% during the forecast period. A steep rise in the prevalence of cardiovascular problems has led to a higher demand for interventional cardiac surgery for diagnosis and treatment.

The hospitals segment dominated the market and held the largest revenue share of 70.8% in 2020. The segment is expected to grow at the fastest rate during the forecast period, owing to an increase in the number of hospitalization of patients with cancer, neurological problems, and cardiovascular diseases.

The diagnostic centers segment is also expected to witness significant growth during the forecast period. The increased knowledge of chronic diseases such as cancer, neurological diseases, and neurodegenerative disorders is the key driver of the segment.

North America dominated the high pressure contrast media injector market and accounted for the largest revenue share of 49.1% in 2020. The region is expected to witness a CAGR of more than 11.0% during the forecast period. Factors such as rapid adoption of modern technologies and enhanced healthcare infrastructure, strong purchasing power, and a fair reimbursement framework are driving the market in North America.

Key Players

  • Bracco Group
  • Guerbet Group
  • Medtron AG
  • Bayer HealthCare LLC
  • ulrich GmbH & Co. KG
  • NemotoKyorindo Co., Ltd.
  • GE Healthcare
  • Sino Medical-Device Technology Co.
  • Apollo RT Co. Ltd.
  • VIVID IMAGING
Report Coverage Details
Market Size US$ 462.8 million by 2030
Growth Rate CAGR of 20.1% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Product, Type, Application, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Bracco Group; Guerbet Group; Medtron AG; Bayer HealthCare LLC; ulrich GmbH & Co. KG; NemotoKyorindo Co., Ltd.; GE Healthcare; VIVID IMAGING; Sino Medical-Device Technology Co., Ltd.; APOLLO RT Co. Ltd.

Market Segmentation

  • Product
    • Injector Systems
    • Consumables
      • Syringes
      • Tubing
      • Others
  • Type
    • Single head injectors
    • Dual head injectors
    • Syringeless injectors
  • Application
    • Interventional cardiology
    • Interventional radiology
    • Endovascular surgery
    • Interventional neuroradiology
  • End-use
    • Hospitals
    • Diagnostic Centers
    • Ambulatory Surgical Centers
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Switzerland
      • Belgium
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Thailand
      • Australia
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38478

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global High Pressure Contrast Media Injectors Market, By Product

7.1.  High Pressure Contrast Media Injectors Market, by Product, 2021-2030

7.1.1.    Injector Systems

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Consumables

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global High Pressure Contrast Media Injectors Market, By Type

8.1.  High Pressure Contrast Media Injectors Market, by Type, 2021-2030

8.1.1.    Single head injectors

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Dual head injectors

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Syringeless injectors

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global High Pressure Contrast Media Injectors Market, By Application

9.1.  High Pressure Contrast Media Injectors Market, by Application, 2021-2030

9.1.1.    Interventional cardiology

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Interventional radiology

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Endovascular surgery

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Interventional neuroradiology

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global High Pressure Contrast Media Injectors Market, By End-user

10.1.        High Pressure Contrast Media Injectors Market, by End-user, 2021-2030

10.1.1.  Hospitals

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Diagnostic Centers

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Ambulatory Surgical Centers

10.1.3.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global High Pressure Contrast Media Injectors Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2017-2030)

11.1.2.  Market Revenue and Forecast, by Type (2017-2030)

11.1.3.  Market Revenue and Forecast, by Application (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Type (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Type (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2017-2030)

11.2.2.  Market Revenue and Forecast, by Type (2017-2030)

11.2.3.  Market Revenue and Forecast, by Application (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Type (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Type (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Type (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Type (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2017-2030)

11.3.2.  Market Revenue and Forecast, by Type (2017-2030)

11.3.3.  Market Revenue and Forecast, by Application (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Type (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Type (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Type (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Type (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2017-2030)

11.4.2.  Market Revenue and Forecast, by Type (2017-2030)

11.4.3.  Market Revenue and Forecast, by Application (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Type (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Type (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Type (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Type (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2017-2030)

11.5.2.  Market Revenue and Forecast, by Type (2017-2030)

11.5.3.  Market Revenue and Forecast, by Application (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Type (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Type (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

Chapter 12.  Company Profiles

12.1.              Bracco Group

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Guerbet Group

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Medtron AG

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Bayer HealthCare LLC

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              ulrich GmbH & Co. KG

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              NemotoKyorindo Co., Ltd.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              GE Healthcare

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Sino Medical-Device Technology Co.

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Apollo RT Co. Ltd.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           VIVID IMAGING

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38478

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Show More

Related Articles

Back to top button